A 61-year-old male patient presented at an outside hospital with back pain. A magnetic resonance image (MRI) without gadolinium noted an incidental 8-cm cystic lesion partially arising from the lower pole of the left kidney. The patient denied hematuria, flank pain, bone pain, weight loss, shortness of breath, cough, or fever. He denied any family history of genitourinary malignancies or any history of smoking. A computed tomography scan of the abdomen and pelvis with and without intravenous and oral intake of contrast demonstrated 3 adjacent cysts in the lower pole of the left kidney, measuring 10.0 × 7.1 × 8.0 cm 3 in aggregate. The dominant cyst within this mass demonstrated an intramural nodularity, calcification, and areas of mild heterogeneous enhancement (Figure 1 ). The dominant lesion measured 6.2 × 6.8 × 6.9 cm 3 and was abutting the collecting system of the left lower pole without gross renal sinus invasion. An MRI abdomen with and without gadolinium performed for better characterization confirmed the presence of a complex cystic lesion arising from the lower pole of the left kidney measuring 11.2 × 7.8 × 9.0 cm 3 . The dominant locule within this cystic lesion measured 7.0 × 7.0 × 8.1 cm 3 and demonstrated mural nodularity, thick septa, and regions of enhancement inferomedially (Figures 2A and 2B) . A 1.3 × 1.0 cm 2 left para-aortic lymph node was visualized but favored to be reactive. A chest X-ray did not show any pulmonary metastasis. Laboratory testing revealed a creatinine of 0.82 mg/ dL, whereas the serum calcium, complete blood count, liver function tests, and urinalysis were all within normal range. After preoperative counseling and informed consent, he underwent a left radical nephrectomy with hilar lymphadenectomy.
solid nodule close to but separate from the main 11.5-cm mass (Figure 3 , arrow). There was no gross invasion of renal sinus or perinephric fat. No adrenal gland was present.
Histologically, the majority of the mass consisted of variably sized cysts lined by flat, cuboidal to hobnailed and bland epithelial cells with a loose and variably cellular stromal background. Subepithelial stromal condensation was noted, which resembled ovarian-type stroma ( Figure 4) . In other regions, the spindle cells revealed significant cytological atypia with large hyperchromatic nuclei, irregular nuclear contours, and prominent nucleoli. The average mitotic count in these atypical regions was 3 mitoses per single high-power field (8 mitoses/10 high-power fields). No rhabdoid or strap-like cells were noted. In these same regions, focally, the epithelial component also revealed cytological atypia, with larger, hyperchromatic nuclei with minimal stratification ( Figure  5 ). Additionally, necrosis was noted in the region of spindle cell proliferation.
The more solid and tan areas of the tumor corresponded to a conventional papillary renal cell carcinoma (PRCC), measuring 2.0 cm in maximum dimension. The papillae were lined by cuboidal cells with high nuclear to cytoplasmic ratio and occasional prominent nucleoli. The stroma of the papillae revealed abundant foamy histiocytes. This component was intimately associated with the aforementioned cystic and stromal elements. Furthermore, the solid golden yellow nodule corresponded to a third component with the classic morphology of a clear cell renal cell carcinoma (CCRCC), nucleolar grade II/IV, and measuring 1.0 cm in maximum dimension ( Figure 6 ). The CCRCC appeared as a distinct focus adjacent and separate from the main lesion. Three hilar lymph nodes that accompanied the specimen were all benign.
Immunohistochemical stains revealed the epithelial cells lining the cystic spaces to be positive for pancytokeratin, CK7, and PAX8 (focally), but being negative for CAIX. Both the bland and sarcomatous stromal component were positive for vimentin and SMA while being negative for estrogen receptor (ER), progesterone receptor (PR), pancytokeratin, CK7, STAT6, HMB45, TLE, myogenin, and desmin. The PRCC was strongly positive for CK7 and racemase while being negative for CAIX, and the CCRCC was strongly positive for CAIX while being negative for CK7 and racemase.
Although a PRCC and CCRCC were identified in this lesion, these 2 components were well circumscribed, of low nuclear grade, and constituted only a minor component of this large 11.5-cm mass. Therefore, sarcomatoid transformation from RCC was unlikely. In addition, the immunohistochemical profile of the tumor with negative cytokeratin staining (panCK) in the spindle cells was not consistent with a sarcomatoid RCC.
The predominant histology of the tumor was that of benign-appearing cysts with associated bland and atypical spindle cells. A differential diagnosis of malignant mixed epithelial and stromal tumor (malignant MEST), angiomyolipoma with epithelial cysts (AMLEC), and other entities such as biphasic synovial sarcoma and sarcomatoid changes arising from RCC were considered. AMLEC is a rare variant of an angiomyolipoma that contains minimal fat with admixed epithelial-lined cysts. This diagnosis can be ruled out, both on morphological and immunohistochemical bases. In the initial description of AMLEC, the tumors contained a single large cyst with dysplastic vessels.
1,2 Our case, however, was composed of variably sized micro-and macro-epithelial-lined cysts without any dysplastic vessels. Furthermore, the HMB-45 stain was negative.
Synovial sarcoma would have been unlikely given the negative TLE and positive PAX8. Furthermore, this entity is characterized by the presence of an (X; 18) translocation, which was negative by fluorescence in situ hybridization. In addition, the significant component of distinctive ovarian-type stroma would be unusual for a biphasic synovial sarcoma.
The biphasic nature of the tumor, combined with foci of ovarian-type stroma with sarcomatous change, supported a diagnosis of malignant MEST of the kidney. Although estrogen and progesterone expression were absent, these stains are not required for the diagnosis of MEST.
Discussion
MEST of the kidney was first described in a case report by Michal and Syrucek in 1998. 3 It was further proposed as a diagnostic entity by both Michal and Adsay in 2000 and thought to represent multiple similar tumors that have been described in the literature under different terminologies, including adult type mesoblastic nephroma, cystic hamartoma of the pelvis, and adult type of cystic nephroma, among others. 4, 5 MESTs of the kidney are predominantly found in perimenopausal women (6:1, female to male ratio [F:M]) at a mean age of 46 years. 5 It is also now recognized as part of a spectrum of the same entity that includes cystic nephroma in adults, as evidenced by gene expression profile analysis. 6 Similar to benign MESTs, malignant MESTs present around an average age of 55 (range 19-84) years, with a female predominance (F:M of 3:1). Most of these tumors are discovered incidentally as part of a workup for flank pain, abdominal discomfort, or hematuria. Of the 3 male patients reported in the literature, 1 patient had a documented history of antiandrogen therapy for prostate cancer. 7 The other reports of male patients include a 19-year-old with a large 28-cm tumor who experienced local recurrence with liver metastasis and a 69-year-old with a 9.5-cm mass. 8, 9 Genetics and Histiogenesis ER and PR expression combined with a female predilection suggest a probable hormonal influence in the histogenesis of the tumor. A report by Adsay et al 5 includes a single male patient who was exposed to estrogen therapy for prostate cancer 4 years before the renal mass was identified. Interestingly, 7 of their female patients had histories of long-term oral estrogen therapy. 5 Our patient did not have any documented history of estrogen therapy. Among the malignant MEST cases reported in the literature, results of ER and PR were documented in 9 reports, with 7 cases expressing one or both receptors. The 2 cases that had absent ER and PR expression were both in male patients (Table 1) .
It was traditionally suggested that only the stromal component of the tumor is neoplastic, whereas the epithelial cysts represent entrapped enlarged renal epithelial tubules. Although molecular genetic analyses have not yielded a specific recurrent genetic defect, X chromosome inactivation analysis supports the neoplastic nature of both the stroma and epithelium, which may have derived from a common cell capable of dual differentiation. 10 
Gross and Microscopic Findings
The majority of MESTs of the kidney are well circumscribed and confined to the kidneys, with a combination of both cystic and solid areas in varying proportions. The cyst lining is typically smooth. Microscopically, the gross appearance of the cystic regions correspond to the benign and flat to cuboidal epithelium-lined cysts, and the intervening solid regions reveal an ovarian stroma-type spindle cell proliferation. There have been 2 reports describing MESTs containing columnar and mucinous epithelium. 11, 12 No specific immunohistochemical stains are consistently expressed; however, ER and PR are positive in the stromal component in 62% and 85% of cases, respectively. 13 Malignant transformation of either the stromal or epithelial component of MEST is an uncommon occurrence. An extensive search of the literature identified only 17 reported cases, summarized in Table 1 . The malignant component in almost all the reports involved the stroma, presenting most commonly as an undifferentiated sarcoma. 7, 8, [14] [15] [16] [17] Other patterns included synovial sarcoma like, 18 rhabdomyosarcoma, 16, [19] [20] [21] and chondrosarcoma. 16, 19, 20 A carcinomatous component was described in 3 patients, presenting as an adenocarcinoma with endometrioid features, 20 PRCC, 22 and a focal large-cell carcinomatous type. 16 The tumors ranged in size from 2.5 to 28 cm in dimension, and 5 reports noted necrosis and/or hemorrhage grossly within the tumor. 8, [16] [17] [18] [21] [22] [23] Most of the cases were accompanied by a typical benign MEST component, with the exception of the case in the report by Sukov et al. 23 Jung et al 16 proposed 4 criteria for the diagnosis of malignant MEST: (1) epicenter of the tumor is in the kidney; (2) there is evidence of benign epithelial and stromal components with ovarian-type stroma; (3) malignant components are intimately associated with the benign counterparts; and (4) primary renal sarcoma and metastasis are excluded. 16 Gross tumor necrosis and hemorrhage should also raise the suspicion for a malignant component as well as other typical features of malignancy, such as invasion of perinephric fat or the renal capsule. The differential diagnosis of a MEST with a malignant stromal component would include a sarcomatoid RCC and a primary renal synovial sarcoma.
Treatment and Outcomes
Almost all the reports of malignant MEST cases underwent a radical nephrectomy. Complete resection with clean surgical margins is vital to patient outcomes in both malignant and benign MEST. In general, tumor disruption during surgery may be associated with poor outcomes. A patient in the case reported by Yap et al 14 developed local recurrence after surgery wherein the tumor was disrupted. Another report described peritoneal seeding of a benign MEST after the patient underwent a robotic-assisted renal cyst marsupialization with a positive cauterized edge on pathology. 24 This patient was later found to have recurrence with renal and paracolonic masses. Some patients have undergone additional treatment with chemotherapy and/or radiation after surgery for disease recurrence. 8, 14, 16 One patient in the case reported by Jung et al 16 received adjuvant chemotherapy for a presumed clinical diagnosis of CCRCC.
Conclusion
Our case highlights a rare example of a malignant MEST with 2 additional malignant epithelial components: an intimately associated PRCC and an adjacent, separate CCRCC in a male patient with no history of hormonal therapy. The case was discussed at the multidisciplinary tumor board, with the consensus that the mass should be treated similarly to a sarcoma with no adjuvant therapy and close observation. There was no evidence of recurrence after 2 years of follow-up.
To our knowledge, this is the first reported case of this kind. The intimate association of the PRCC with MEST and histological findings of focal areas of epithelial cytological atypia support the notion that both the epithelium and stroma of MEST are neoplastic. There have not been any studies that investigated the presence of additional molecular events that account for the progression of benign MEST to malignancy or the influence of hormonal therapy. It is also unclear whether a particular morphology or differentiation of the malignant MEST component corresponds to poor long-term outcomes.
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